Back

Evaluation of the effectiveness of lisinicore and losartan in patients with chronic heart failure

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure - Clinical Comorbidities HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Umida Kamilova

Republican Specialized Scientific-Practical Medical Center Therapy and Medical Rehabilitation, Tashkent (Uzbekistan)

24 More presentations in this session

Presentation thumbnail
Profile and follow up of the elderly patient with heart failure
Doctor D. Enriquez Vazquez (A Coruna, ES)
Abstract
Presentation thumbnail
Impaired filtration and tubular kidney functions in patients with chronic heart failure with a moderately reduced left ventricular ejection fraction and persistent atrial fibrillation
Professor N. Koziolova (Perm, RU)
Abstract
Presentation thumbnail
The impact of diabetes mellitus and microvascular complications on heart failure biomarkers
Doctor F. Fringu (Cluj Napoca, RO)
Abstract
Presentation thumbnail
What is the difference in clinical, instrumental characteristics and prognosis in patients with CHF and rLVEF in regard to the presence and nature of the iron deficiency state?
Doctor V. Gorbachova (Aarau, CH)
Abstract
Presentation thumbnail
Left ventricular systolic dysfunction in asymptomatic patients with diabetes mellitus type 1 is associated with duration of disease, obesity and poor glycemic control
Doctor C. Kapelios (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure - Clinical

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Presentation
Cardio-Kidney-metabolic overlap in HFpEF: cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF
thumbnail
Congress Session
Chronic kidney disease and heart failure
thumbnail
Congress Presentation
Impact of multimorbidity on mortality in heart failure with mildly reduced and preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources